Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to ...

Sabre (NASDAQ:SABR – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses ...

Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

A very well-timed investment into a medical AI company has more than doubled Pelosi's investment in just three weeks.

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Let's explore the Tempus AI stock price and whether it is a good company to buy and hold despite its overvaluation.

Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each trade, it is ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...